EUR 5.0
(3.08%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 43.75 Million EUR | 9.69% |
2022 | 39.89 Million EUR | 9.91% |
2021 | 36.29 Million EUR | 606.42% |
2020 | 5.13 Million EUR | -24.51% |
2019 | 6.8 Million EUR | -41.09% |
2018 | 11.55 Million EUR | 169.64% |
2017 | 4.28 Million EUR | -72.45% |
2016 | 15.55 Million EUR | 184.16% |
2015 | 5.47 Million EUR | -37.65% |
2014 | 8.78 Million EUR | 541.34% |
2013 | 1.36 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 42.53 Million EUR | 6.62% |
2023 Q4 | 43.75 Million EUR | 2.88% |
2023 FY | 43.75 Million EUR | 9.69% |
2022 Q4 | 39.89 Million EUR | 0.02% |
2022 Q2 | 39.88 Million EUR | 1140.3% |
2021 Q2 | 4.85 Million EUR | -5.57% |
2021 Q4 | 3.21 Million EUR | -33.72% |
2020 Q4 | 5.13 Million EUR | -8.45% |
2020 Q2 | 5.61 Million EUR | -17.54% |
2019 Q2 | 5.9 Million EUR | -48.92% |
2019 Q4 | 6.8 Million EUR | 15.32% |
2018 Q2 | 15.69 Million EUR | 266.21% |
2018 Q4 | 11.55 Million EUR | -26.37% |
2017 Q4 | 4.28 Million EUR | -59.16% |
2017 Q2 | 10.49 Million EUR | -32.55% |
2016 Q2 | 20.61 Million EUR | 276.65% |
2016 Q4 | 15.55 Million EUR | -24.56% |
2015 Q4 | 5.47 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Nicox S.A. | 52.98 Million EUR | 17.407% |
FERMENTALG | 50.24 Million EUR | 12.909% |
argenx SE | 4.11 Billion EUR | 98.936% |
BioSenic S.A. | 9.55 Million EUR | -357.768% |
Celyad Oncology SA | 16.28 Million EUR | -168.751% |
Hyloris Pharmaceuticals SA | 47.68 Million EUR | 8.228% |
Onward Medical N.V. | 43.62 Million EUR | -0.296% |
Oxurion NV | 6.55 Million EUR | -568.061% |
PHAXIAM Therapeutics S.A. | 51.3 Million EUR | 14.713% |
Financière de Tubize SA | 1.92 Billion EUR | 97.721% |
UCB SA | 15.53 Billion EUR | 99.718% |